Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recent progress in anti-HIM-1 research].

Masanori Baba1

  • 1Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University 8-35-1, Sakuragaoka, Kagoshima 890-8544, Japan. baba@m.kufm.kagoshima-u.ac.jp

Uirusu
|September 29, 2004
PubMed
Summary

Highly active antiretroviral therapy (HAART) improved HIV-1 prognosis but led to drug resistance. New therapies, including fusion inhibitors, target different mechanisms to overcome resistance in HIV-1 treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-activity relationship of neplanocin A analogues for the identification of novel anti-HBV leads.

Organic & biomolecular chemistry·2026
Same author

Potential of fat-soluble vitamins as a platform for antiviral drug development.

Bioorganic & medicinal chemistry letters·2025
Same author

Design, Synthesis, and Anti-SARS-CoV-2 Activity of Amodiaquine Analogs.

Chemical & pharmaceutical bulletin·2025
Same author

Pyrazolo[3,4-<i>d</i>]pyrimidine-based neplanocin analogues identified as potential <i>de novo</i> pharmacophores for dual-target HBV inhibition.

RSC medicinal chemistry·2025
Same author

<i>In Silico</i> Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations.

The journal of physical chemistry. B·2025
Same author

Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro.

Journal of natural medicines·2024

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Context:

  • Highly active antiretroviral therapy (HAART) has significantly improved HIV-1 infection outcomes.
  • Long-term HAART use is associated with challenges, notably the emergence of drug-resistant HIV-1 strains.

Purpose:

  • To review novel therapeutic strategies for overcoming drug resistance in HIV-1 infection.
  • To highlight compounds with new mechanisms of action against resistant HIV-1.

Summary:

  • New reverse transcriptase inhibitors (RTIs) and protease inhibitors (PIs) offer once-daily dosing and activity against resistant strains.
  • A newly licensed virus entry (fusion) inhibitor is effective against HIV-1 resistant to RTIs and PIs by targeting a different mechanism.
  • Ongoing research includes CCR5 antagonists, and inhibitors targeting integrase, HIV-1 gene expression, and virion assembly.

Related Experiment Videos

Impact:

  • Development of more effective treatments for HIV-1, including those resistant to current therapies.
  • Potential for improved patient adherence and reduced treatment burden through novel drug formulations and targets.
  • Advancement in the field of HIV-1 therapeutics, offering hope for managing complex and resistant infections.